Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|August 13, 2013
NS5A inhibitor, daclatasvir, for the treatment of chronic hepatitis C virus infectionD Alan Herbst, K Rajender ReddyJournal of Cardiology|July 14, 2022
Interaction between donor obesity and prolonged donor ischemic time in heart transplantationSamuel T Kim, Mark R Helmers, Amit Iyengar, et al.JHLT Open|March 27, 2025
Brain atrophy in heart failure patients following left ventricular assist device implantation or heart transplantationD Alan Herbst, Banafsheh Shakibajahromi, Michael V Genuardi, et al.Journal of Cardiac Failure|July 27, 2021
HCV-Positive Allograft Use in Heart Transplantation Is Associated With Increased Access to Overdose Donors and Reduced Waitlist Mortality Without Compromising OutcomesPeter J Altshuler, Mark R Helmers, Alexis R Schiazza, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 15, 2021
Assessing predicted heart mass size matching in obese heart transplant recipientsSamuel T Kim, Mark R Helmers, Amit Iyengar, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 1, 2021
The modified US heart allocation system improves transplant rates and decreases status upgrade utilization for patients with hypertrophic cardiomyopathyCody C Fowler, Mark R Helmers, Benjamin Smood, et al.Advanced Therapeutics|June 28, 2021
Superoxide Dismutase-Loaded Nanoparticles Attenuate Myocardial Ischemia-Reperfusion Injury and Protect Against Chronic Adverse Ventricular RemodelingPeter J Altshuler, Alexis R Schiazza, Lijun Luo, et al.Pageof 1